• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>IMS Health

IMS Health

Putnam Investors A PINVX 2 Star

Last Price$24.82Day Change (%)-0.20%
Open Price$24.82Day Change ($)-0.05
Day Range24.82–24.8252-Week Range20.03–25.01

As of Fri 04/28/2017 | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Dr. Reddy's Laboratories Announces the Launch of Ezetimibe and Simvastatin Tablets in the U.S. Market

    Dr. Reddy's Laboratories Announces the Launch of Ezetimibe and Simvastatin Tablets in the U.S. Market

  2. UPDATE: Amgen likely aiming to meet, not beat, first-quarter earnings expectations

    UPDATE: Amgen likely aiming to meet, not beat, first-quarter earnings expectations

  3. Pricey rare disease drug's launch will be likely focus of Biogen earnings

    Pricey rare disease drug's launch will be likely focus of Biogen earnings

  4. Amgen likely aiming to meet, not beat, first-quarter earnings expectations

    Amgen likely aiming to meet, not beat, first-quarter earnings expectations

  5. Dr. Reddy's Laboratories Announces the Launch of Progesterone Capsules in the U.S. Market

    Dr. Reddy's Laboratories Announces the Launch of Progesterone Capsules in the U.S. Market

  6. Our Take on the Second Quarter

    Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.

  7. Trouble in Plain Sight

    IMS Health is on the right track for growth.

  8. Our Take on the Fourth Quarter

    A look back at the winners and losers of the final quarter of a tumultuous year.

©2017 Morningstar Advisor. All right reserved.